Tango Therapeutics, Inc.
NASDAQ:TNGXBiotechnology
Healthcare
$22.71 -10.03%
-$3.24 today
- Market cap
- $3.85B
- Beta
- 1.19
- P/E (TTM)
- -38.9
- EPS (TTM)
- -$0.75
52W Low $4.60High $34.39
Volume 1.81M
Average 3.67M
Price history
Tango Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+173.94%
Period high
$32.90
Period low
$8.29
Latest
$22.71
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Nov 13, 2026 | Nov 13, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Oct 23, 2026 | Oct 23, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does Tango Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about TNGX's filings, answered from its disclosures.
What is the latest TNGX filing?
The latest filing shown is 4 dated Nov 13, 2026.
How many recent filings does TNGX have?
Intrinsic Alpha currently shows 20 recent filings for TNGX.
Continue the stock analysis
Jump to another research area for this company.